MARSICANO, RENATO MARIA
MARSICANO, RENATO MARIA
Universita' degli Studi di MILANO
Circulating tumor DNA: a biomarker for oncology drug development in phase I clinical trials?
2025 R. Asnaghi, R.M. Marsicano, V. Fuorivia, G. Malvezzi, J.D. Etessami, D. Izzo, C. Valenza, G. Curigliano, D. Trapani
Molecular tumor board in patients with metastatic breast cancer
2025 L. Boscolo Bielo, E. Guerini Rocco, E. Crimini, M. Repetto, M. Lombardi, C. Zanzottera, G. Aurilio, M. Barberis, C. Belli, Y. Zhan, E. Battaiotto, J. Katrini, R. Marsicano, P. Zagami, B. Taurelli Salimbeni, A. Esposito, D. Trapani, C. Criscitiello, N. Fusco, A. Marra, G. Curigliano
Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy
2025 D. Izzo, L. Ascione, L. Guidi, R.M. Marsicano, C. Koukoutzeli, D. Trapani, G. Curigliano
Molecular tumour board in gastrointestinal cancers
2025 L. Boscolo Bielo, E. Crimini, M. Repetto, M. Barberis, E. Battaiotto, J. Katrini, E. Martino, G. Gaudio, M. Lombardi, C. Zanzottera, G. Aurilio, C. Belli, Y. Zhan, V. Fuorivia, R.M. Marsicano, J.D. Etessami, P. Zagami, A. Marra, D. Trapani, B. Taurelli Salimbeni, C. Criscitiello, D. Ciardiello, B. Lavinia, L. Gervaso, C.A. Cella, F. Spada, M.G. Zampino, N. Fusco, N. Fazio, E. Guerini Rocco, G. Curigliano
PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments
2024 C. Valenza, R.M. Marsicano, D. Trapani, G. Curigliano
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients
2010 A. Di Carlo, A. Mariano, D. Terracciano, M. Ferro, V. Montanaro, M. Marsicano, G. Di Lorenzo, V. Altieri, V. Macchia